レポートナンバー 0000036083
スペインの感染症検査市場（2023年）- 検査別の2022年のサプライヤーシェアと2022年から2027年の売上セグメント予測、競合情報、新興技術、機器、およびサプライヤーの機会
VPGMarketResearch
2023 Spain Infectious Disease Testing Market: 2022 Supplier Shares and 2022-2027 Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
発刊日
2023/07/18
言語英語
体裁PDF
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
レポート概要
この新しいレポートは、今後5年間に感染症検査市場に出現する主要なビジネスチャンスを戦略的に分析したものです。このレポートは、スペイン市場の主要な傾向を調査しています。現在および新たなアッセイをレビューし、革新的な診断技術の潜在的な応用を分析します。また、100を超える感染症検査の量と売上高をアッセイ、市場セグメント、国ごとに予測し、方法（分子、血清学/免疫診断、培養/顕微鏡）ごとの検査量の推定値を提供します。さらに、主要なプレーヤーと潜在的な市場参入者のプロフィールを作成し、サプライヤーに代替の事業拡大戦略を提案します。
理論的根拠
この包括的なレポートは、診断業界の幹部や、ダイナミックで急速に拡大する微生物検査市場への多角化を計画している企業が、新たな機会を評価し、効果的なビジネス戦略を開発する際に役立ちます。
微生物検査は、体外診断業界で最も急速に成長している分野の1つであり、この10年間にサプライヤーが直面する最大の課題です。主な原動力の中には、依然として世界の主要な健康上の脅威であり、日和見感染症の増加に寄与する主要な要因であるエイズの蔓延が続いていることが挙げられる。バイオテロの脅威。分子診断技術の進歩。そして免疫抑制剤の利用範囲が広がります。
一部の感染症では病因が依然として謎に包まれていますが、他の感染症では最初の臨床症状が現れるずっと前から原因微生物が微量濃度で存在しており、最近の遺伝子工学と検出技術の進歩により、高感度、特異的、低コストの製品を実現する刺激的な機会が生まれています。
機会と戦略的推奨事項
- 今後5年間で、市場に大きな魅力をもたらす新しい機器、試薬キット、IT、その他の製品の新たな機会
- 分散検査製品の設計基準
- 代替の市場浸透戦略。
- 潜在的な市場参入障壁とリスク
このレポートで分析された感染症
エイズ/HIV、アデノウイルス、エロモナド、バルトネラ、ヒト胚盤胞菌、カンピロバクター、カンジダ、下疳、クラミジア、クロストリジウム、コロナウイルス、コクサッキーウイルス、クリプトスポリジウム、シクロスポラ、CMV、大腸菌、エコーウイルス、脳炎、エンテロウイルス、EBV、ジアルジア、淋病、肉芽腫鼠径ウイルス、ハンタウイルス、ヘリコバクター・ピロリ、肝炎、ヘルペス・インフルエンザ、レジオネラ菌、ライム病、リンパ肉芽腫、マラリア、麻疹、髄膜炎、小胞子菌、単核球症、おたふく風邪、マイコプラズマ、HPV、パルボウイルス、肺炎、ポリオーマウイルス、シュードモナス、狂犬病、RSV、ライノウイルス、ロタウイルス、風疹、サルモネラ菌、敗血症、赤癬、ブドウ球菌、連鎖球菌、梅毒、トキソプラズマ症、トリコモナス、結核、ビブリオ、西ナイル、エルシニア
市場セグメンテーション分析
- 主要サプライヤーの個別検査および国別の売上高と市場シェア
-
国、個別の検査、市場セグメント別の100を超える感染症検査の数量と売上予測
➣ 病院
➣ 血液銀行
➣ 商業/民間研究所
➣ 医師の診療所/グループ診療所
➣ 公衆衛生研究所
- 方法別の検査量の推定（分子、血清学/免疫診断、培養/顕微鏡検査）
- 市場のダイナミクス、傾向、構造、規模、成長、および国ごとの主要サプライヤーのレビュー
現在の製品と新製品
- 100 を超える主要な病気について、その病因、現在の診断検査、ワクチン、薬剤、市場のニーズなどを詳細に調査します。
- 感染症検査に使用される主な分析装置の動作特性、機能、販売価格などをレビューします。
技術レビュー
- 分子診断、モノクローナル抗体、イムノアッセイ、その他の技術と感染症検査への潜在的な応用の評価。
- 個別の検査による感染症診断製品を開発または販売している企業の世界的なリスト
競合評価
-
主要サプライヤーと新興市場参入者の販売、製品ポートフォリオ、マーケティング戦術、協力体制、研究開発における新製品などの戦略的評価
レポート詳細
目次
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
b. Diagnostic Tests
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
43. Microsporidium
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
46. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
62. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed by Abbott,
Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and
Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
GSK Biologicals
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Lonza
Myriad Genetics
OrthoQuidel
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Japan Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
Japan
Hospital Laboratories Infectious Disease Test
Volume Forecast
Japan
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
Japan
AIDS Testing Market Diagnostics Sales by
Major Supplier
Japan
Campylobacter Testing Market Diagnostics Sales by Major
Supplier
Japan
Candida Testing Market Diagnostics Sales by
Major Supplier
Japan
Chlamydia Testing Market Diagnostics Sales by
Major Supplier
Japan
CMV Testing Market Diagnostics Sales by
Major Supplier
Japan
Gonorrhea Testing Market Diagnostics Sales by
Major Supplier
Japan
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Hepatitis C Testing Market Diagnostics Sales by Major
Supplier
Japan
Herpes Testing Market Diagnostics Sales by
Major Supplier
Japan
Legionella Testing Market Diagnostics Sales Forecast by Major
Supplier
Japan
Meningitis Testing Market Diagnostics Sales by Major
Supplier
Japan
Mononucleosis Testing Market Diagnostics Sales by Major
Supplier
Japan
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
Japan
Pneumonia Testing Market Diagnostics Sales by
Major Supplier
Japan
RSV Testing Market Diagnostics Sales by Major Supplier
Japan
Rotavirus Testing Market Diagnostics Sales by Major
Supplier
Japan
Rubella Testing Market Diagnostics Sales by Major
Supplier
Japan
Septicemia Testing Market Diagnostics Sales by Major
Supplier
Japan
Shigella Testing Market Diagnostics Sales by Major
Supplier
Japan
Streptococci Testing Market Diagnostics Sales by Major
Supplier
Japan
Syphilis Testing Market Diagnostics Sales by Major
Supplier
Japan
Toxoplasmosis Testing Market Diagnostics Sales by Major
Supplier
Japan
Trichomonas Testing Market Diagnostics Sales by
Major Supplier
Japan
Tuberculosis Testing Market Diagnostics Sales by Major
Supplier
